Source: Eur Respir J 2008; 31: 223-225
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Teramoto S., Yamaguchi Y., Yamamoto H., Hanaoka Y., Ishii M., Hibi S., Ishii T., Kume H., Ouchi Y.. Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients. Eur Respir J 2008; 31: 223-225

Member's Comments

No comment yet.

Related content which might interest you: Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Impact of sleep onset on hemodynamic parameters in obese patients with or without obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Daytime ventilatory instability in obese patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2001; 18: Suppl. 33, 334s Year: 2001 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Effect of continuous positive airway pressure therapy on metabolic control in patients with morbid obesity and obstructive sleep apnoea Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy Source: Annual Congress 2009 - Clinical aspects of sleep apnoea Year: 2009 The influence of obesity and overweight on hypercapnic and hypoxic respiratory responses in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 183s Year: 2003 Cardiovascular morbidity and obstructive sleep apnoea in children Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children Year: 2009